Search clinical trials for: Heparin low dose

Total 39779 results

University of Liege

Not yet recruiting

Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery

Protamine Adverse Reaction | Protamine Dose
Tabba Heart Institute
InnoTherapy Inc

Recruiting

Low Dose Heparin Factorial Trial

Radial Artery Occlusion

Pakistan
Ege University

Recruiting

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism

Pulmonary Embolism

Turkey
Consorci Sanitari de l'Alt Penedès i Garraf

Recruiting

Heparinization vs Salinization of the Peripheral Venous Catheter

Catheter Complications

Spain
Mount Sinai Hospital, Canada

Recruiting

Low Molecular Weight hEparin vs. Aspirin Post-partum (LEAP)

Venous Thromboembolism

Canada
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
Pirogov Russian National Research Medical University

Recruiting

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. (IDAHeT)

Venous Thromboembolism

Russian Federation
Grupo de Investigación Clínica en Oncología Radioterapia
Hospital del Mar; Hospital Universitari Sant Joan de Reus; Hospital Universitario...

Recruiting

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Pneumonia, Viral

Spain
Rigshospitalet, Denmark
University Hospital Bispebjerg and Frederiksberg; Hillerod Hospital, Denmark; Herlev and Gentofte Hospital and other collaborators

Recruiting

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY)

Pulmonary Embolism

Denmark
Population Health Research Institute

Recruiting

Higher vs. Lower Dose Heparin for PCI (HD-PCI)

Cardiovascular Diseases | Percutaneous Coronary Intervention

Canada
University of Aarhus

Recruiting

Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism (BETULA)

Pulmonary Embolism

Denmark
Benha University

Recruiting

Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin

Recurrent Pregnancy Loss

Egypt
Xuanwu Hospital, Beijing

Completed

Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy (SELECT)

Cerebral Angiography | Heparinization

China
Central Hospital, Nancy, France
Ministry of Health, France; University Hospital of Saint-Etienne; Grand Est Region

Completed

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 (COVI-DOSE)

Thrombosis | Deep Vein Thrombosis | COVID | Pulmonary Embolism

France
Karolinska Institutet

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Covid19 | Thromboembolism

Sweden
Universitätsklinikum Hamburg-Eppendorf

Completed

Hamburg Edoxaban for Anticoagulation in COVID-19 Study (HERO-19)

Covid19

Germany
University Hospital, Ghent

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

COVID-19 | Critical Illness | Deep Vein Thrombosis | Anticoagulants and Bleeding Disorders

Belgium
HaEmek Medical Center, Israel

Completed

anti10a Levels in Women Treated With LMWH in the Postpartum Period

Venous Thromboembolism

Israel
Azidus Brasil

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Healthy

Brazil
Hospital Universitario Infanta Leonor

Completed

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Covid19 | Thrombosis

Spain
Assistance Publique - Hôpitaux de Paris

Completed

ANTIcoagulation in Severe COVID-19 Patients (ANTICOVID)

Severe COVID-19 Pneumonia

France
Fundación de investigación HM
Syntax for Science, S.L

Terminated

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Covid-19

Spain
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Fayoum University Hospital

Withdrawn

Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy

High Risk Pregnancy

Egypt
Fundacion GenesisCare
Hospital La Milagrosa; Hospital Vithas Valencia Consuelo

Suspended

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 (ULTRA-COVID)

Pneumonia, Viral | Cytokine Storm

Spain
Robert F. James
Indiana University School of Medicine

Suspended

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)

Neurobehavioral Manifestations | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, Intracranial | Intracranial Aneurysm | Heparin-induced Thrombocytopenia Type II

United States
Venus Remedies Limited

Completed

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Healthy

India
Cedars-Sinai Medical Center
Genentech, Inc.

Terminated

Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism

COVID | Pulmonary Embolism

United States
University Hospital, Geneva

Terminated

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation (COVID-HEP)

COVID | Sars-CoV2

Switzerland
University of Colorado, Denver

Completed

Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery

Venous Thrombosis

United States
Victor Tapson, MD
Bristol-Myers Squibb

Terminated

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism (SAFE-LYSE)

Pulmonary Embolism | Right Ventricular Dysfunction | Right Ventricular Failure | Pulmonary Embolism With Acute Cor Pulmonale | Pulmonary Embolism With Pulmonary Infarction | Pulmonary Embolism Subacute Massive

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

Thrombophlebitis

Italy
Medical University of Gdansk
Baxter Healthcare Corporation

Unknown

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis

Poland
Ain Shams University

Unknown

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

Coronavirus Disease (COVID)19

Egypt
Karolinska Institutet

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Covid-19 | Bleeding | Thromboembolic Events

Sweden
HaEmek Medical Center, Israel

Completed

A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity

Obesity | Anticoagulant | Apixaban

Israel
Lawson Health Research Institute

Completed

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Kidney Failure

Canada
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
PrECOG, LLC.
Celgene

Terminated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction (PrE1003)

Multiple Myeloma | Plasma Cell Neoplasm

United States
Shanghai First Maternity and Infant Hospital

Unknown

Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women

Recurrent Implantation Failure

China
University of Southern California
National Cancer Institute (NCI); Celgene Corporation

Terminated

Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma

United States
University of Arizona

Withdrawn

Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.

Bleeding | Acute Respiratory Failure | Extracorporeal Membrane Oxygenation Complication

United States
McMaster University
Heart and Stroke Foundation of Ontario

Completed

Fixed Dose Heparin Study

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada, New Zealand
University of North Carolina, Chapel Hill
Laboratory Corporation of America; IntraPump Infusion Systems

Completed

Once Weekly Subcutaneous Ports for the Administration of Anticoagulants

Venous Thromboembolism

United States
GlaxoSmithKline

Completed

Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) (FUTURA/OASIS 8)

Acute Coronary Syndrome

Canada, France, Bulgaria, Germany, Poland, United Kingdom, Spain, Russian Federation, Korea, Republic of, Netherlands, India, United States, Brazil, Hungary, Italy, Argentina, Czech Republic, Greece
McMaster University

Terminated

Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation (PACEBRIDGE)

Hemorrhage | Thromboembolism | Cardiac Arrhythmias

Canada
Beijing Anzhen Hospital

Unknown

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

LOVASTATIN/TICAGRELOR [VA Drug Interaction]

China
University of Arkansas
National Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.

Completed

Effects of Exercise in Combination With Epoetin Alfa

Multiple Myeloma

United States
Duke University
Eisai Limited

Completed

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Sickle Cell Disease | Vaso-occlusive Crisis

United States
Indonesia University

Completed

Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis

Severe Sepsis With Septic Shock | Severe Sepsis Without Septic Shock

Indonesia

Search clinical trials for: Heparin low dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations